Influenza Vaccines for the Future

  • Rino Rappuoli
  • Giuseppe Del Giudice

Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Evolution and Epidemiology

    1. Front Matter
      Pages 1-1
    2. Samira Mubareka, Peter Palese
      Pages 3-26
    3. Lone Simonsen, Cécile Viboud, Robert J. Taylor, Mark A. Miller
      Pages 27-54
    4. W. Abdullah Brooks, Mark C. Steinhoff
      Pages 55-75
    5. Robert G. Webster, Richard J. Webby, Michael Perdue
      Pages 77-93
    6. Benjamin Greenbaum, Vladimir Trifonov, Hossein Khiabanian, Arnold Levine, Raul Rabadan
      Pages 95-111
  3. Immunity and Vaccine Strategies

    1. Front Matter
      Pages 113-113
    2. Romina Libster, Kathryn M. Edwards
      Pages 149-171
    3. Justine D. Mintern, Carole Guillonneau, Stephen J. Turner, Peter C. Doherty
      Pages 173-197
    4. Emanuele Montomoli, Barbara Capecchi, Katja Hoschler
      Pages 199-222
    5. Catherine J. Luke, Kanta Subbarao
      Pages 223-272
    6. Harry Greenberg, George Kemble
      Pages 273-291
    7. Philip R. Dormitzer
      Pages 293-312
    8. Derek T. O’Hagan, Theodore Tsai, Steven Reed
      Pages 327-357
    9. Wouter Koudstaal, Fons G. UytdeHaag, Robert H. Friesen, Jaap Goudsmit
      Pages 383-398
  4. Economic and Social Implications

    1. Front Matter
      Pages 399-399
    2. Giuseppe Del Giudice, Rino Rappuoli
      Pages 401-423
    3. Julia A. Walsh, Cyrus Maher
      Pages 425-440
  5. Back Matter
    Pages 441-446

About this book


The emergence of H5N1 avian influenza in 1997 and of the influenza A H1N1 of swine origin in 2009 calls for new, rapid and sustainable solutions for both seasonal and pandemic influenza viruses. During the last ten years, science and technology have made enormous progress, and we are now able to monitor in real time the genetics of viruses while they spread globally, to make more powerful vaccines using novel adjuvants, and to generate viruses in the laboratory using reverse genetics. This volume not only provides state-of-the-art information on the biology of influenza viruses and on influenza vaccines, but is also designed to be a resource to face the present H1N1 pandemic and to plan for long-term global and sustainable solutions.


Influenza Vaccine

Editors and affiliations

  • Rino Rappuoli
    • 1
  • Giuseppe Del Giudice
    • 2
  1. 1.Novartis Vaccines & Diagnostics S.r.l.SienaItaly
  2. 2.Novartis Vaccines & Diagnostics S.r.l.SienaItaly

Bibliographic information

Industry Sectors
Health & Hospitals